Latest Sirona Biochem Corp. (SRBCF) Headlines
Sirona Biochem Closes Private Placement
Marketwire - Thu Mar 06, 4:26PM CST
Sirona Biochem Corp. (TSX-V: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company") is pleased to announce that it has closed its private placement in the amount of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit consists of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share of the Company for a period of three years from the date of issue at a price of $0.20 per share.
Sirona Arranges $1.2M Private Placement
Marketwire - Tue Feb 25, 3:52PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company") announces that it has arranged, subject to TSX Venture Exchange acceptance, a private placement of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit will consist of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share for a period of three years from the date of issue at a price of $0.20 per share. The private placement is fully subscribed.
Sirona Grants Stock Options
Marketwire - Wed Feb 19, 7:09PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company") announces that it has granted, under its stock option plan, incentive stock options to directors, officers and consultants for the purchase of up to 300,000 common shares of the Company at a price of $0.15 per share for a period of five years.
Economic Investment Trust Limited Announces Dividend
Marketwire - Wed Feb 12, 12:33PM CST
The Board of Directors of Economic Investment Trust Limited (TSX: EVT) today declared a cash dividend of $7.20 per Common Share payable March 31, 2014 to shareholders of record on March 14, 2014.
DA Saddened By Passing of Ben Skosana [press release]
All Africa Global Media - Wed Feb 12, 12:32PM CST
The Democratic Alliance is saddened by the passing of National Assembly House Chairperson and IFP Member of Parliament, Ben Skosana last night.
Sirona Biochem Completes Global Exclusive Licensing Agreement with Obagi Medical Products
Marketwire - Wed Jan 29, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) announced today the formal execution of the global exclusive licensing agreement with Obagi Medical Products (Obagi) for the commercialization of skin lightening compound TFC-849. Sirona Biochem will receive a licensing fee and ongoing royalty payments for global product sales from Obagi Medical Products.
Sirona Biochem Completes Exclusive Licensing Agreement With Leading Anti-Diabetic Company in China, Wanbang Biopharmaceuticals
Marketwire - Mon Jan 27, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX:SRBCF) announced today the completion of an exclusive licensing agreement with Wanbang Biopharmaceuticals (Wanbang Biopharma). Sirona Biochem will provide an exclusive license to Wanbang Biopharma to develop and commercialize Sirona's anti-diabetic SGLT2 inhibitor in the People's Republic of China (PRC).In exchange for this license, Wanbang Biopharma will provide upfront and milestone payments of up to US$9.5M in addition to royalty payments for product sales in the PRC.
Sirona Biochem Appoints David Moore to Board of Directors
Marketwire - Thu Jan 23, 2:20PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX:SRBCF) announced today the appointment of David Moore to its Board of Directors.
Sirona Biochem Announces License Agreement with Cincinnati Children's Hospital Medical Center
Marketwire - Wed Jan 15, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX:SRBCF) and Cincinnati Children's Hospital Medical Center announce the formalization of a license agreement of Cincinnati Children's patented synthetic vernix technology.
Sirona Biochem Announces Collaboration with Jean-Michel Cousteau, Fabien Cousteau, and Explore Green
Marketwire - Mon Jan 13, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF) announces a collaboration with Jean-Michel Cousteau, Fabien Cousteau, (respective son and grandson of Jacques Cousteau) and Explore Green LLC.
Sirona Biochem Announces CAD$5.3 Million Private Placement
Marketwire - Wed Jan 08, 4:33PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB), (the "Company") announced today a non-brokered private placement of up to 33,400,000 units of the Company at a price of $0.16 CAD each (a "Unit") for gross proceeds of up to CAD$5,344,000 (the "Private Placement").
Sirona Biochem Closes Private Placement
Marketwire - Thu Mar 06, 4:26PM CST
Sirona Biochem Corp. (TSX-V: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company") is pleased to announce that it has closed its private placement in the amount of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit consists of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share of the Company for a period of three years from the date of issue at a price of $0.20 per share.
Sirona Arranges $1.2M Private Placement
Marketwire - Tue Feb 25, 3:52PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company") announces that it has arranged, subject to TSX Venture Exchange acceptance, a private placement of 9,230,770 units at $0.13 per unit for total gross proceeds of $1,200,000. Each unit will consist of one common share and one transferable share purchase warrant, each warrant exercisable into one additional common share for a period of three years from the date of issue at a price of $0.20 per share. The private placement is fully subscribed.
Sirona Grants Stock Options
Marketwire - Wed Feb 19, 7:09PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company") announces that it has granted, under its stock option plan, incentive stock options to directors, officers and consultants for the purchase of up to 300,000 common shares of the Company at a price of $0.15 per share for a period of five years.
Economic Investment Trust Limited Announces Dividend
Marketwire - Wed Feb 12, 12:33PM CST
The Board of Directors of Economic Investment Trust Limited (TSX: EVT) today declared a cash dividend of $7.20 per Common Share payable March 31, 2014 to shareholders of record on March 14, 2014.
DA Saddened By Passing of Ben Skosana [press release]
All Africa Global Media - Wed Feb 12, 12:32PM CST
The Democratic Alliance is saddened by the passing of National Assembly House Chairperson and IFP Member of Parliament, Ben Skosana last night.
Sirona Biochem Completes Global Exclusive Licensing Agreement with Obagi Medical Products
Marketwire - Wed Jan 29, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) announced today the formal execution of the global exclusive licensing agreement with Obagi Medical Products (Obagi) for the commercialization of skin lightening compound TFC-849. Sirona Biochem will receive a licensing fee and ongoing royalty payments for global product sales from Obagi Medical Products.
Sirona Biochem Completes Exclusive Licensing Agreement With Leading Anti-Diabetic Company in China, Wanbang Biopharmaceuticals
Marketwire - Mon Jan 27, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX:SRBCF) announced today the completion of an exclusive licensing agreement with Wanbang Biopharmaceuticals (Wanbang Biopharma). Sirona Biochem will provide an exclusive license to Wanbang Biopharma to develop and commercialize Sirona's anti-diabetic SGLT2 inhibitor in the People's Republic of China (PRC).In exchange for this license, Wanbang Biopharma will provide upfront and milestone payments of up to US$9.5M in addition to royalty payments for product sales in the PRC.
Sirona Biochem Appoints David Moore to Board of Directors
Marketwire - Thu Jan 23, 2:20PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX:SRBCF) announced today the appointment of David Moore to its Board of Directors.
Sirona Biochem Announces License Agreement with Cincinnati Children's Hospital Medical Center
Marketwire - Wed Jan 15, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX:SRBCF) and Cincinnati Children's Hospital Medical Center announce the formalization of a license agreement of Cincinnati Children's patented synthetic vernix technology.
Sirona Biochem Announces Collaboration with Jean-Michel Cousteau, Fabien Cousteau, and Explore Green
Marketwire - Mon Jan 13, 6:46AM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF) announces a collaboration with Jean-Michel Cousteau, Fabien Cousteau, (respective son and grandson of Jacques Cousteau) and Explore Green LLC.
Sirona Biochem Announces CAD$5.3 Million Private Placement
Marketwire - Wed Jan 08, 4:33PM CST
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB), (the "Company") announced today a non-brokered private placement of up to 33,400,000 units of the Company at a price of $0.16 CAD each (a "Unit") for gross proceeds of up to CAD$5,344,000 (the "Private Placement").
